Araki S, Chikazawa K, Ohkusa T, Ijima K, Usui K, Motoyama M, Tamada T
Endocrinol Jpn. 1983 Dec;30(6):753-62. doi: 10.1507/endocrj1954.30.753.
The method of pulsatile administration of gonadotropin-releasing hormone (Gn-RH) has been proven as a useful means for induction of ovulation in anovulatory women. In our series of clinical trials, 23 out of 29 anovulatory patients ovulated with pulsatile administration of Gn-RH. Seven patients who ovulated volunteered for the present study with daily hormonal analysis and follicular sonometory . Two patients have oligomenorrhea, 3 patients secondary amenorrhea-1st grade (the sole administration of gestagen required for withdrawal bleeding) and the remaining 2 patients secondary amenorrhea-2nd grade (the combined administration of estrogen and gestagen required for withdrawal bleeding). A diagnosis of hyperprolactinemia was made for one patient with secondary amenorrhea-1st grade. Pulsatile administration of Gn-RH was performed by the use of a self-administered infuser . The infuser was connected to an i.v. indwelling catheter via a specially designed blood backflow eliminater . Five micrograms or less of Gn-RH was given every 2 hr from 07:00 to 23:00 hr daily. Five patients received HCG during the preovulatory period. In one patient, a short term treatment of HMG was added to Gn-RH treatment. Follicular sonometry revealed the development of a single dominant follicle which reached between 20 and 28 mm (23.7 +/- 0.12 mm, mean +/- S.E.) in diameter at the preovulatory period. Disappearance of a dominant follicle was recognized in the early luteal phase. Characteristic increases in estradiol were recognized concomitantly with the development of a dominant follicle. Progesterone levels after ovulation were within the limits of its normal "luteal phase" rise. The present data suggest that pulsatile administration of low dose Gn-RH with nocturnal interruption of treatment is effective for normal progress of follicular development in various types of anovulatory patients, culminating in single ovulation. This paper includes the discussion on our method which may be responsible for a high success rate of ovulation induction.
促性腺激素释放激素(Gn-RH)脉冲给药法已被证明是诱导无排卵女性排卵的一种有效方法。在我们的一系列临床试验中,29例无排卵患者中有23例通过Gn-RH脉冲给药实现了排卵。7例排卵的患者自愿参加本研究,接受每日激素分析和卵泡超声检查。2例患者月经过少,3例继发性闭经1级(撤药性出血仅需给予孕激素),其余2例继发性闭经2级(撤药性出血需联合给予雌激素和孕激素)。1例继发性闭经1级的患者被诊断为高催乳素血症。Gn-RH脉冲给药通过使用自我给药注射器进行。该注射器通过一个专门设计的血液回流消除器与静脉留置导管相连。每天从07:00至23:00每2小时给予5微克或更少的Gn-RH。5例患者在排卵前期接受了人绒毛膜促性腺激素(HCG)治疗。1例患者在Gn-RH治疗中加用了短期的人绝经期促性腺激素(HMG)治疗。卵泡超声检查显示在排卵前期有单个优势卵泡发育,直径达20至28毫米(平均23.7 +/- 0.12毫米,平均值 +/- 标准误)。在黄体早期可见优势卵泡消失。随着优势卵泡的发育,雌二醇有特征性升高。排卵后孕酮水平在正常“黄体期”升高范围内。目前的数据表明,低剂量Gn-RH脉冲给药并在夜间中断治疗对各类无排卵患者卵泡发育的正常进展有效,最终导致单卵泡排卵。本文包括对我们的方法的讨论,该方法可能是排卵诱导成功率高的原因。